BlackRock Group’s Kindred Biosciences, Inc. KIN Stock Holding History

BlackRock Group’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$63K	Hold	14,850	–	–	﹤0.01%	2890
2016 Q3	$74K	Hold	14,850	–	–	﹤0.01%	2864
2016 Q2	$53K	Hold	14,850	–	–	﹤0.01%	2902
2016 Q1	$51K	Hold	14,850	–	–	﹤0.01%	2922
2015 Q4	$50K	Hold	14,850	–	–	﹤0.01%	2828
2015 Q3	$77K	Hold	14,850	–	–	﹤0.01%	2766
2015 Q2	$101K	Hold	14,850	–	–	﹤0.01%	2744
2015 Q1	$106K	Hold	14,850	–	–	﹤0.01%	2642
2014 Q4	$111K	Buy	+14,850	New	+$126K	﹤0.01%	2647

Other funds holding KIN

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

BlackRock Group's KIN Position: Q4 2016 in Review

BlackRock Group held its Kindred Biosciences, Inc. (KIN) position steady in Q4 2016 at 14,850 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #2890.

BlackRock Group first reported a position in KIN in Q4 2014 and has held it in 9 quarters since. The position peaked at $111K in Q4 2014. 43 funds tracked by Wall St. Rank hold KIN as of Q4 2016.

BlackRock Group held 14,850 shares of Kindred Biosciences, Inc. worth $63K as of Q4 2016.
BlackRock Group left its Kindred Biosciences, Inc. share count unchanged in Q4 2016.
Kindred Biosciences, Inc. made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2890 holding.
BlackRock Group first reported a position in Kindred Biosciences, Inc. in Q4 2014 and has held it in 9 quarters since.
BlackRock Group's Kindred Biosciences, Inc. position peaked at $111K in Q4 2014.
43 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.